Status:
RECRUITING
The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With ESRD
Lead Sponsor:
Bundang CHA Hospital
Conditions:
End-Stage Renal Disease
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
To determine the effectiveness of magnetic stimulation application on alleviating back pain and maintaining muscle mass in patients with end-stage renal disease.
Eligibility Criteria
Inclusion
- Adults aged 19 years or older
- Patients diagnosed with end-stage renal failure and receiving dialysis treatment more than three times a week
- Back pain intensity of 4 points or higher on the visual analogue scale (VAS)
- Those with cognitive function that can clearly indicate NRS with a score of 23 points or higher, the criterion for determining cognitive impairment on the Mini Mental State Examination (MMSE) \[14\]
- Those who voluntarily decided to participate in this clinical trial after receiving a detailed explanation and fully understanding it and gave written consent to comply with the precautions
Exclusion
- If the pain is due to trauma
- If it is difficult to participate in the study due to serious mental illness (e.g. schizophrenia, bipolar disorder, etc.) or psychological instability.
- Patients with severe neurological illness (e.g. stroke, severe dementia, etc.).
- Those with poor general condition due to unstable cardiovascular, digestive, respiratory, or endocrine systems, or severe internal medical illness such as systemic infection
- Patients participating in other therapeutic clinical trials or those who have participated in other therapeutic clinical trials within the past 30 days (observational studies are not relevant)
- If there are contraindications to magnetic stimulation
- Patients with implanted medical devices (e.g. pacemakers)
- Metal objects are inserted into the skull
- A wound on the skin at the attachment site
- History of epilepsy
- Cervical pain or musculoskeletal disease
- Pregnant and lactating women
Key Trial Info
Start Date :
August 6 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 19 2026
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT06982573
Start Date
August 6 2025
End Date
February 19 2026
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHA Bundang Medical Center, CHA University
Seongnam-si, Gyeonggi-do, South Korea, 463-712